Paper41190079
Integrated immunodominant epitope discovery for dual-purpose rapid and economical diagnostic and immunoprotective applications against MRSA.
Chen L and 15 others. Front Immunol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Integrated immunodominant epitope discovery for dual-purpose rapid and economical diagnostic and immunoprotective applications against MRSA. Papers, record 41190079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41190079
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrated immunodominant epitope discovery for dual-purpose rapid and economical diagnostic and immunoprotective applications against MRSA.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Immunodominant Epitopes | Major topic |
| Staphylococcal Infections | Major topic |
| Staphylococcal Vaccines | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Antigens, Bacterial | |
| Female | |
| Disease Models, Animal | |
| Antibodies, Bacterial |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29691393 | Vaccines work. | Nat Commun | 2018 | https://conductscience.org/library/papers/29691393 | PubMed |
| 2 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 3 | 24586678 | Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins. | PLoS One | 2014 | https://conductscience.org/library/papers/24586678 | PubMed |
| 4 | 37516573 | The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial. | Vaccine | 2023 | https://conductscience.org/library/papers/37516573 | PubMed |
| 5 | 11372026 | Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. | J Infect Dis | 2001 | https://conductscience.org/library/papers/11372026 | PubMed |
| 6 | 36828665 | UreB immunodominant epitope-specific CD8+ T-cell responses were beneficial in reducing gastric symptoms in Helicobacter pylori-infected individuals. | Helicobacter | 2023 | https://conductscience.org/library/papers/36828665 | PubMed |
| 7 | 24949641 | Isolation and epitope mapping of staphylococcal enterotoxin B single-domain antibodies. | Sensors (Basel) | 2014 | https://conductscience.org/library/papers/24949641 | PubMed |
| 8 | 33353987 | A guide to vaccinology: from basic principles to new developments. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33353987 | PubMed |
| 9 | 25392350 | Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. | J Clin Microbiol | 2015 | https://conductscience.org/library/papers/25392350 | PubMed |
| 10 | 26490505 | Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection. | Sci Rep | 2015 | https://conductscience.org/library/papers/26490505 | PubMed |
| 11 | 31149870 | Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus. | Hum Vaccin Immunother | 2019 | https://conductscience.org/library/papers/31149870 | PubMed |
| 12 | 29483570 | Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model. | Sci Rep | 2018 | https://conductscience.org/library/papers/29483570 | PubMed |
| 13 | 36958134 | Staphylococcus aureus vaccine strategy: Promise and challenges. | Microbiol Res | 2023 | https://conductscience.org/library/papers/36958134 | PubMed |
| 14 | 32172183 | Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms. | Curr Opin Microbiol | 2020 | https://conductscience.org/library/papers/32172183 | PubMed |
| 15 | 33582806 | Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33582806 | PubMed |
| 16 | 36423648 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. | Lancet | 2022 | https://conductscience.org/library/papers/36423648 | PubMed |
| 17 | 39146354 | Novel Antibody-Based Protection/Therapeutics in Staphylococcus aureus. | Annu Rev Microbiol | 2024 | https://conductscience.org/library/papers/39146354 | PubMed |
| 18 | 24599257 | Fine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptides. | PLoS One | 2014 | https://conductscience.org/library/papers/24599257 | PubMed |
| 19 | 36656850 | The trehalose glycolipid C18Brar promotes antibody and T-cell immune responses to Mannheimia haemolytica and Mycoplasma ovipneumoniae whole cell antigens in sheep. | PLoS One | 2023 | https://conductscience.org/library/papers/36656850 | PubMed |
| 20 | 40193249 | Management of Staphylococcus aureus Bacteremia: A Review. | JAMA | 2025 | https://conductscience.org/library/papers/40193249 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42440476 | Adjuvant-driven epitope hierarchy correlates with the protective efficacy of FimA vaccine against Klebsiella pneumoniae. | Front Immunol | 2026 | https://conductscience.org/library/papers/42440476 | PubMed |
| 42353100 | Immunodominant IgM Epitopes of the Angiostrongylus cantonensis Galectin-1 and Galectin-2 Proteins Recognized by Patients' Sera: Optimization of an ELISA Assay for Human Acute Diagnosis of Angiostrongyliasis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353100 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41190079
GET https://conductscience.org/api/papers/v1/41190079/references?page=2